Share Name Share Symbol Market Type Share ISIN Share Description
Bluwater Bio LSE:BWB London Ordinary Share KYG119491077 ORD 0.5P (DI)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 1.00p 0.00p 0.00p - - - 0.00 05:00:10
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
- - - - 0.00

Bluwater Bio Share Discussion Threads

Showing 101 to 118 of 125 messages
Chat Pages: 5  4  3  2  1
DateSubjectAuthorDiscuss
21/8/2010
16:09
http://www.wateronline.com/article.mvc/Bluewater-Bio-Secures-4M-Investment-From-0001?VNETCOOKIE=NO
kooba
22/4/2010
11:03
ceo on cnbc this am...all seems to be going very well. technology proven now going for roll out...strong institutional backing etc not sure if there will ever be easy accessed liquidity in these but since last fundraise at 12p one would have to think per share value must be in mid high teens with the interest in the sector and the progress the company is making.imho.
kooba
26/10/2009
17:09
kooba...Thanks for the info.
ted32
26/10/2009
07:15
+-----------------------------------+------------------------------------+ | Press Release | 26 October 2009 | +-----------------------------------+------------------------------------+ Bluewater Bio International ("Bluewater Bio" or the "Company") Bluewater Bio expands into South Africa Bluewater Bio International, the provider of a high-performance yet highly cost-effective proprietary wastewater treatment process called HYBACS, is pleased to announce that it has signed an exclusive representation agreement in South Africa via a license agreement with Headstream Water Holdings ("Headstream"). The agreement is for an initial three year period and the license can be extended for further two year periods in perpetuity if Headstream achieves certain sales targets. Headstream is looking at projects nationally in South Africa and the initial focus will be on restoring performance and upgrading plants in particularly stressed areas and on private sector operated plants serving mining communities. There are three projects under consideration in the North West Province and one in Mpumalanga, in the north eastern part of the country. HYBACS is particularly attractive in these regions because it avoids large civil works and can provide up to 50% energy savings which is a major issue in South Africa. Headstream is currently negotiating a co-operation agreement with the largest independent operator of wastewater plants in South Africa. Daniel Ishag, CEO of Bluewater Bio commented: "South Africa is a priority region for Bluewater Bio because many plants in the country are dysfunctional. This is down to poor maintenance, lack of capital expenditure and, most importantly, overloading because of population growth." "The market opportunity in South Africa is significant, there are 1,619 wastewater plants registered with the Department of Water Affairs. Official estimates suggest approximately 60% of these are dysfunctional to a greater or lesser degree in terms of regulatory compliance of stipulated water quality characteristics - industry sources hint that this is closer to 80%. These are predominantly the smaller municipalities as the larger urban centres still have capable technical staff, but even this infrastructure is deteriorating. There is no doubt that the remainder of the sub?Saharan African countries are in a far worse predicament and South Africa will be our central base as we enter this market." The management team of Headstream, whose offices in Johannesburg and Cape Town will officially open in January 2010, will be headed up by Justin Moore. Justin has over 30 years of investment banking experience and has advised major water utilities in South Africa for example Umgeni Water and Rand Water. Martie Janse Van Rensburg will join the Headstream Board as its non executive Chairperson. Martie, who is the current chairperson of Johannesburg Water and the former CEO of the Trans-Caledon Tunnel Authority which implements and funds raw bulk water infrastructure in South Africa, is highly respected in the water sector in South Africa. Bluewater Bio and Headstream expect to expand into other sub?Saharan African countries approximately 12-18 months after the South African launch. - ENDS - For further information, please contact: +---------------------------------------------+--------------------------+ | Bluewater Bio International | | +---------------------------------------------+--------------------------+ | Daniel Ishag | Tel: +44 (0) 20 7907 | | | 9820 | +---------------------------------------------+--------------------------+ | daniel.ishag@bluewaterbio.com | www.bluewaterbio.com | +---------------------------------------------+--------------------------+
kooba
16/8/2009
16:29
Bluewater Bio Makes Water from Sewage with New HYBACS System http://cleantechnica.com/2009/08/01/bluewater-bio-makes-water-from-sewage-with-new-hybacs-system/
kooba
16/8/2009
16:27
Bluewater Bio installs HYBACS wastewater treatment plant for Spain`s Aqualia Source: Bluewater Bio Aug. 3, 2009 http://www.environmental-expert.com/resultEachPressRelease.aspx?cid=27008&codi=59472&lr=1
kooba
04/4/2009
20:08
04/04 ft. Clear water? Bluewater Bio International was a pioneer of the growing trend for companies to quit Aim. In November, it surprised the market by deciding to leave just 11 months after raising £2.7m at 12½p a share, only to see its valuation fade away. The notice for the extraordinary meeting featured the list of reasons to delist that have become something of a mantra for companies leaving the market. It asserted that "the current investment climate is such that it is substantially more straightforward for private companies to raise finance than small-cap public companies". The company has proved its point by raising a further £2.3m for the equivalent of 12½p a share from Aqua Resources Fund. Its revolutionary technology, which treats effluent to produce water that can be used again, was last week signed up by Nesma, a leading contractor in Saudi Arabia. The flotation was not premature, insists Daniel Ishag, chief executive. "We had a clear strategy, and being a public company put us on the world's radar . . . . All in all it was definitely worth it, and we are still able to benefit now." It's a back-handed compliment that Aim could do without. Copyright The Financial Times Limited 2009
kooba
23/3/2009
16:52
more good news...would be another blue day if quoted!! http://www.bluewaterbio.com/pdf/Bluewater%20Bio%20and%20Nesma%20Group%20JV%20-%20Press%20release%2023%20March%202009.pdf
kooba
17/3/2009
17:07
i believe they thought they were better placed to raise serious money without the "distraction" of the listing...seems they were right!! enjoy your pint!
kooba
17/3/2009
16:59
kooba I'm now off to the pub. Many thanks for your insight. But why delist? I'm sure that BWB could have raised the money still being quoted on aim. Thank you kooba.
ted32
17/3/2009
16:51
ted32,yes in a word.company definately alive and kicking with £2.32m of new capital. as far as i can tell the company has just raised new money at 12 times suspension price ie 12p.i am awaiting bwb to call me back but i believe this is correct.market cap at suspension 2.48m @ 1p now they are selling sub 8% stake i calculate roughly to be 18.75m new shares new shares for £2.32m which i make 12.37p per share.fingers crossed will post again once confirmed.
kooba
17/3/2009
16:44
kooba Many thanks for the information. I attempted to get a share certificate from bluewater when they delisted but I was told by Barclays Stockbrokers that they were in admin. Having seen this new info I logged on to BWB website but could not find anything. Having written off £5000 through this investment are you telling me kooba that I stand a good chance to get my money back?
ted32
17/3/2009
16:08
unless my numbers are wrong..this would appear to involve a transaction in existing stock at around 10p and a subscription for new shares at circa 12p.double checking but certainly appears to be 10 times suspension price.
kooba
17/3/2009
16:06
RNS Number : 9991O Aqua Resources Fund Limited 17 March 2009 AQUA RESOURCES ANNOUNCES INVESTMENT IN BLUEWATER BIO INTERNATIONAL 17 March 2009 - Aqua Resources Fund Limited ("Aqua"), the closed-ended investment company managed by FourWinds Capital Management ("FWCM") established to invest in global water opportunities, announced today that it has entered into certain arrangements with regard to an investment of up to approximately 15 per cent. of the fully diluted share capital of Bluewater Bio International ("BBI" or "Bluewater Bio") a company incorporated in the Cayman Islands and involved in the design and marketing of an advanced biological solution for the treatment of wastewater. BBI focuses on selling its proprietary wastewater technology, HYBACS, to both the municipal treatment sector and to industrial consumers and polluters of water. This investment follows Aqua's initial joint venture agreement with the Ranhill Group to invest in water and wastewater operations in the People's Republic of China and Thailand, in November 2008. The investment announced today fits well with Aqua's strategy as it not only adds an attractive set of technologies focusing on wastewater treatment and water recycling, but also a very good geographic coverage with partnerships and clients in both Western and Eastern Europe as well as the Middle East. Furthermore BBI has moved towards signing reference plants and distribution contracts with high profile water players. BBI creates an excellent fit in many business areas for Aqua. Part of the investment in BBI by Aqua (representing 8.51 per cent. of the existing ordinary share capital of BBI) has been acquired by Aqua from FWCM for an aggregate sum of US$ 2.97 million (EUR 2.30 million). This purchase constitutes a smaller related party transaction to which the provisions of UKLA Listing Rule 11.1.10R apply and have been complied with. BDO Stoy Hayward LLP has been appointed by the Company as its sponsor to act in relation to this aspect of the transaction. Following this purchase, FWCM retains a holding of 0.07 per cent. of the existing issued share capital of BBI. Aqua has also entered into legally binding heads of terms, subject to definitive legal documentation and necessary shareholder, board and third party approvals to be obtained by BBI, under which Aqua has agreed to invest further cash, by way of a subscription for new ordinary shares and warrants of BBI, in order to increase its shareholding following its purchase from FWCM (as referred to above) from 8.51 per cent. to up to 16.13 per cent. of the enlarged issued share capital of BBI (14.94 per cent. of the share capital, fully diluted after the exercise of existing options and warrants), at an additional aggregate cost of approximately GBP2.32 million (EUR 2.51 million). Hasan Askari, Chairman of Aqua's Board of Directors, said "The Board is delighted to announce Aqua's second transaction which positions Aqua with a strategic investment in a fast growing technology company bringing innovative solutions to the municipal and industrial wastewater sector". Foreign exchange calculations have been based on the following rates: US$ EUR 0.7757and GBP EUR 0.9227. Further enquiries: FourWinds Capital Management, Investment Manager Kimberly Tara, Chief Executive Officer Valerie Daoud Henderson, Head of Europe Environment Group Jui Kian Lim, Head of Asia Environment Team info@fourwindscm.com BDO Stoy Hayward LLP, Sponsor John Stephan +44 (0)121 352 6200 Cenkos Securities plc, Corporate Broker Will Rogers +44 (0)20 7397 1920 Dion Di Miceli +44 (0)20 7397 1921 HSBC Securities Services (Guernsey) Limited, Administrator Tel: +44 (0) 1481 707 000 Citigate Dewe Rogerson, PR Advisor Sarah Gestetner /Lindsay Noton +44 207 638 9571 Disclaimers End
kooba
15/2/2009
19:04
http://business.maktoob.com/NewsDetails-20070423210130-Zero_Waste_Technology_appointed_as_exclusive_representative_for_Bluewater_Bio_International_in_Jordan_Kuwait_Bahrain_and_Saudi_Arabia_.htm http://www.saudigazette.com.sa/index.cfm?method=home.regcon&contentID=2009020628541
kooba
18/11/2008
12:32
kooba...must admit I was a bit taken back by the aqualia contract only days after the delisting. It surely must have made a positive impact on the share price if the co had not delisted. Applied for share certificate so perhaps not all is lost.
ted32
17/11/2008
22:05
http://www.cleantech.com/news/3881/bluewater-aqualia-sign-5-year-wastewater-deal bit more info on the deal.
bubface
14/11/2008
12:12
for interest to any holders that do not wish to hold i believe boutique investment bank novus capital www.novus-cap.com are prepared to mop up any loose holders at around suspension price if anyone wants out.
kooba
Chat Pages: 5  4  3  2  1
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:41 V: D:20161211 13:53:20